SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 133 filers reported holding SYNAGEVA BIOPHARMA CORP in Q1 2015. The put-call ratio across all filers is 3.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $17,017,000 | -0.9% | 174,476 | -5.7% | 0.01% | +20.0% |
| Q4 2014 | $17,173,000 | +102.8% | 185,079 | +50.3% | 0.01% | +66.7% |
| Q3 2014 | $8,468,000 | -56.1% | 123,118 | -33.1% | 0.00% | -50.0% |
| Q2 2014 | $19,293,000 | +72.6% | 184,100 | +36.7% | 0.01% | +50.0% |
| Q1 2014 | $11,175,000 | +14.0% | 134,694 | -11.0% | 0.00% | +33.3% |
| Q4 2013 | $9,799,000 | +10.4% | 151,407 | +8.2% | 0.00% | 0.0% |
| Q3 2013 | $8,872,000 | +70.6% | 139,962 | +13.0% | 0.00% | +50.0% |
| Q2 2013 | $5,200,000 | -40.6% | 123,865 | -34.5% | 0.00% | -50.0% |
| Q4 2012 | $8,754,000 | -14.8% | 189,110 | -1.6% | 0.00% | 0.0% |
| Q3 2012 | $10,270,000 | +125.5% | 192,205 | +71.2% | 0.00% | +100.0% |
| Q2 2012 | $4,555,000 | – | 112,301 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|